Understanding Biosimilars Legislation in the U.S. & Europe: Strategies for Prosecution, Due Diligence and Litigation of Biologics
May 16, 2011
London, United Kingdom
Finnegan partners Sanya Sukduang and Anthony Tridico will teach a seminar discussing FDA regulatory aspects of the U.S. biosimilar legislation as compared to EU guidelines, patent protection strategies for biologic products, selecting which patents to assert and navigating the patent exchange process, and strategies for successfully litigating a biologics patent infringement lawsuit. The Management Forum program will take place at the Rembrandt Hotel in London, United Kingdom. For more information, or to register, please see Management Forum’s website.